Recent research focusing on Semaglutide at a dosage of 40mg is shedding new light on its potential benefits. Preliminary findings suggest that this higher dosage may amplify the drug's ability to manage blood levels, potentially offering more significant outcomes for individuals with insulin resistance. Further research is underway to fully explore